CClinicalTrials.gg
RecruitingNCT06212791EXCLAMATORYUpdated Mar 12, 2026

EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation

An observational study in Paroxysmal Atrial Fibrillation, sponsored by Virginia Commonwealth University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Virginia Commonwealth University · Observational

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

Longitudinal, observational cohort study to evaluate changes in left atrial (LA) reservoir function during exercise and overall exertional capacity in patients following catheter ablation for paroxysmal atrial fibrillation (AF).

Read the detailed description

EXCLAMATORY is a longitudinal observational cohort clinical research study to evaluate the effects of catheter ablation for paroxysmal atrial fibrillation on left atrial and left ventricular performance during exercise, as well as effects on overall exercise capacity

02

Conditions studied

  • Paroxysmal Atrial Fibrillation

Browse trials for

Keywords

  • Catheter ablation
  • Exercise capacity
03

In context

Atrial Fibrillation

3,870 studies on the registry are indexed under Atrial Fibrillation; 924 are open to participants now.

This study's planned enrollment of 50 is below the median of 300 across 1,363 observational studies indexed under Atrial Fibrillation.

Browse Atrial Fibrillation studies →

Lead sponsor

Virginia Commonwealth University is the lead sponsor of 641 studies on the registry; 82 are open to participants now.

Of its 88 completed or terminated interventional studies of FDA-regulated products, 62 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

In patients undergoing catheter ablation for paroxysmal AF, reduction or elimination of arrhythmia burden will result in favorable LA reverse remodeling - which will result in improved LA reservoir function reserve during exercise, thereby augmenting LV stroke volume reserve during exercise.

Inclusion criteria

  • Age ≥18 years
  • Diagnosis of paroxysmal AF
  • Left ventricular ejection fraction ≥50%
  • Scheduled for catheter ablation
  • Able to speak, hear, and read English
  • Willing and able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Persistent or permanent AF
  • Prior ablation (catheter based or surgical) for AF
  • Significant sinus node dysfunction
  • Implanted pacemaker or defibrillator
  • Contraindication to or inability to complete cardiovascular magnetic resonance study
  • Contraindication to or inability to complete exercise testing
  • Chronic kidney disease with estimated glomerular filtration rate \<30 mL/min/1.73m2
  • Severe left ventricular hypertrophy
  • Unrelated cardiomyopathy that is expected to limit exercise capacity, including but not limited to:

    • Hypertrophic cardiomyopathy
    • Cardiac amyloidosis
    • Constrictive pericarditis
  • Pulmonary arterial hypertension
  • Prior cardiac surgery
  • Active pregnancy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients under going catheter ablation

    Patients undergoing catheter ablation for paroxysmal AF, reduction or elimination of arrhythmia burden

    Behavioral: Self- Report Evaluation-Duke Activity Status Index · Behavioral: Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire · Diagnostic Test: Cardiopulmonary exercise test (CPET) · Diagnostic Test: Transthoracic echocardiogram · Diagnostic Test: Ambulatory cardiac rhythm assessment · Diagnostic Test: Cardiovascular magnetic resonance (CMR)

Interventions

  • BehavioralSelf- Report Evaluation-Duke Activity Status Index

    Complete the Self- Report Evaluation-Duke Activity Status Index

  • BehavioralSelf- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire

    Complete the Self- Report Evaluation, Atrial Fibrillation Effect on Quality of Life Questionnaire

  • Diagnostic testCardiopulmonary exercise test (CPET)

    Cardiopulmonary exercise test (CPET)

  • Diagnostic testTransthoracic echocardiogram

    Transthoracic echocardiogram at rest and immediately following peak exercise during CPET

  • Diagnostic testAmbulatory cardiac rhythm assessment

    Ambulatory cardiac rhythm assessment

  • Diagnostic testCardiovascular magnetic resonance (CMR)

    Cardiovascular magnetic resonance (CMR) study at rest and during two stages of submaximal exercise (ExeCMR)

06

What researchers measure

Primary outcomes

  1. Change in LA reservoir function reserve at submaximal exercise after catheter ablation in patients with paroxysmal AF.

    Change in LA reservoir volume reserve from baseline to follow up, change in left ventricular (LV) stroke volume reserve from baseline to follow up, correlation between changes in LA reservoir volume reserve and changes in LV stroke volume reserve. Therefore the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.

    Time frame: Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.

Secondary outcomes

  1. Change in LV stroke volume reserve at submaximal exercise after catheter ablation in patients with paroxysmal AF.

    Change in LA reservoir volume reserve from baseline to follow up, change in LV stroke volume reserve from baseline to follow up, correlation between changes in LA reservoir volume reserve and changes in LV stroke volume reserve.

    Time frame: Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.

  2. Correlation between changes in LA reservoir volume reserve and changes in LV stroke vol reserve after catheter ablation in patients with paroxysmal AF

    Correlation between changes in LA reservoir volume reserve and changes in LV stroke volume reserve after catheter ablation in patients with paroxysmal AF

    Time frame: Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.

  3. Correlation between changes in LA reservoir function reserve at submaximal exercise and changes in mixed venous oxygen tension (pVO2) .

    Correlation between changes in LA reservoir function reserve at submaximal exercise and changes in pVO2 after catheter ablation

    Time frame: Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.

  4. Correlation between changes in LV stroke volume reserve at submaximal exercise and changes in pVO2

    Correlation between changes in LV stroke volume reserve at submaximal exercise and changes in pVO2 after catheter ablation.

    Time frame: Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.

  5. Correlation between baseline AF burden and LA function, LV Function and pVO2

    Correlation between baseline AF burden and LA function (rest and exercise), LV function (rest and exercise), and pVO2

    Time frame: Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.

  6. Correlation between the amount of AF burden reduction and the changes in LA function, LV function (rest and exercise), and pVO2.

    Correlation between the amount of AF burden reduction and the changes in LA function (rest and exercise), LV function (rest and exercise), and pVO2.

    Time frame: Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06212791
Lead sponsor
Virginia Commonwealth University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Sponsor
First posted
Jan 19, 2024
Start date
Dec 26, 2024
Primary completion
Mar 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Mar 12, 2026

Study contacts

Pamela Grizzard
Contact
pamela.grizzard@vcuhealth.org
804-628-6234
Melissa Sears
Contact
melissa.sears@vcuhealth.org
804-828-1601
Cory Trankle
principal investigator · Virginia Commonwealth University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion